Company / Named in our posts
XenoTherapeutics.
Follow XenoTherapeuticsA Massachusetts-based 501(c)(3) research foundation focused on advancing xenotransplantation through scientific research, clinical development, and public education.[1]
01Deal

Deals on Carrywatch
Every deal that names XenoTherapeutics, and its role in each.
XenoTherapeutics / ESSA
XenoTherapeutics completes acquisition of ESSA Pharma
See deal detailsDeal Web
XenoTherapeutics and 1 firm it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01ESSA Announces Completion of Arrangement with XenoTherapeutics
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming XenoTherapeutics:
- P01